Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1339 of 5804
-
New biologic drug solrikitug aims to tame COPD inflammation
Disease control Recruiting nowA Randomized, Double-blind, Placebo-controlled, Multiple Dose-Ranging Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Solrikitug in Participants with Chronic Obstructive Pulmonary Disease (COPD).
Phase: PHASE2 • Sponsor: Uniquity One (UNI) • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could testosterone shots keep prostate cancer at bay?
Disease control Recruiting nowThe WOMBAT study will test if BAT can prolong the time it takes for nmCRPC prostate cancer to become detectable in other areas of the body (metastatic disease). Approximately 69 participants over the age of 18 with castrate resistant prostate cancer, no evidence of metastatic di…
Phase: PHASE2 • Sponsor: Australian and New Zealand Urogenital and Prostate Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug combo targets Hard-to-Treat pancreatic tumors
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of sunitinib malate in combination with lutetium Lu 177 dotatate in treating patients with pancreatic neuroendocrine tumors. Sunitinib malate is in a class of medications called kinase inhibitors and a form of targe…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a tailored palliative care approach improve life for heart failure patients?
Symptom relief Recruiting nowThere is evidence for the effectiveness and feasibility of the individual components of TIER-HF-PC, however there is a need to test how these individual components interact to allow the researchers to deliver TIER-HF-PC as a model of care in its totality. In the short term, this …
Phase: NA • Sponsor: National Cancer Centre, Singapore • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
New liposomal drug takes on advanced cancers
Disease control Recruiting nowAn Open-label, Phase I Dose Escalation and Phase 2 Dose Expansion Study to Assess Safety, Tolerability, Preliminary Antitumor Activity of SMP 3124LP in Adults with Advanced Solid Tumors
Phase: PHASE1, PHASE2 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New drug combo aims to outsmart resistant leukemia
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of eltanexor in combination with venetoclax for the treatment of patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) that has come back after a period of improvement (relapsed) or that has n…
Phase: PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New chemo cocktail aims to tackle rare brain tumors
Disease control Recruiting nowThis trial is a prospective single arm intervention study, conducting clinical research on marketed drugs. Adverse drug reactions are controllable and the risk is low, with an estimated total of 40 cases. The main objective is to evaluate the safety and efficacy of teniposide com…
Phase: PHASE2 • Sponsor: Chengcheng Guo • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Ancient herb takes on fatty liver: new trial begins
Disease control ENROLLING_BY_INVITATIONThis is a Phase III, multicentre, randomized, double-blind, placebo-controlled, interventional study designed to evaluate the efficacy and safety of a standardized fraction of Picrorhiza kurroa Royal Ex Benth (Picroliv®) in adults with Non-Alcoholic Fatty Liver Disease (NAFLD). …
Phase: NA • Sponsor: Bioagile Therapeutics Pvt. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Extra sleep may help kids lose weight and sharpen memory
Disease control Recruiting nowMore2Sleep is a randomized, controlled, parallel trial with two groups (sleep extension vs control) including 142 school-aged children (6-12 years) who have a BMI above average, defined as age- and sex-specific BMI Z-score above zero using WHO reference standards, and habitually …
Phase: NA • Sponsor: University of Copenhagen • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New heart valve device aims to fix leaky tricuspid without open surgery
Disease control Recruiting nowThe study is an early feasibility study to measure individual patient clinical outcomes and effectiveness, evaluate the safety and function of the DUO Transcatheter Tricuspid Coaptation Valve System (DUO System).
Phase: NA • Sponsor: CroiValve Limited • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a night owl pill fix bipolar mood swings?
Symptom relief Recruiting nowThe purpose of this study is to test whether a dietary supplement (low-dose melatonin) commonly used to treat night owls, administered in conjunction with a behavioral sleep intervention, will help to shift the brain clock earlier and improve mood and sleep in bipolar disorder. E…
Phase: PHASE2 • Sponsor: Leslie Swanson • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New oxygen therapy may limit heart damage after attack
Disease control Recruiting nowThe SuperSaturated Oxygen Comprehensive Observational Registry (SSCORE) registry, a prospectively designed observational study, aims to evaluate the clinical utility, infarct size reduction, and cost-effectiveness of SSO2 Therapy versus PCI alone among patients with anterior AMI …
Sponsor: TherOx • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New combo vaccine aims to shield seniors from RSV and HMPV
⭐️ VACCINE ⭐️ OngoingThe main purposes of this study are to assess the safety, reactogenicity and immunogenicity of 4 dose levels of the bivalent combination Respiratory Syncytial Virus (RSV) / human Metapneumovirus (hMPV) vaccine candidate VXB-241 when administered as a single-dose regimen to health…
Phase: PHASE1 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:35 UTC
-
Simple DNA test could reveal hidden bladder cancer before surgery
Diagnosis Recruiting nowThis trial aims at investigating the diagnostic ability of a combined diagnostic panel including systematic endoscopic evaluation (SEE), blood-based ctDNA assay, and urine-based cfDNA assay to predict the presence of residual tumor remaining in the bladder at cystectomy. Patient…
Sponsor: Fox Chase Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC
-
Cancer drug pelabresib gets Long-Term safety check in extension trial
Disease control Recruiting nowThe purpose of this study is to evaluate the long-term safety and the clinical benefit of pelabresib in patients with hematological and/or solid tumor indications or advanced malignancies. Additionally, participants previously enrolled in studies with pelabresib who received plac…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New online platform aims to boost HIV testing and care for transgender women
Prevention OngoingThe proposed research focuses on developing and testing a web-based platform, called Jom-TestPlus, that will incorporate HIV self-testing (HIVST) with real-time e-counseling (eHIVST) with online-to-offline (O2O) linkage to HIV prevention and treatment services while simultaneousl…
Phase: NA • Sponsor: University of Connecticut • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
Can a simple screening program stop opioid addiction before it starts?
Prevention OngoingThe primary objective of the present pilot, sequential, multiple-assignment randomized trial (Pilot SMART) is to determine feasibility and acceptability of delivering (from the perspective of the treatment/intervention staff) and receiving (from the perspective of the patient) an…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Sleep fix for depression? brain study tests CBT-I
Symptom relief Recruiting nowThis project is the second phase of a two-phased project investigating the impact of a proven sleep intervention, Cognitive Behavioral Therapy for Insomnia (CBT-I) on engagement of the emotion regulation brain network as a putative mechanistic target.
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
Can a shot help kids with eczema sleep through the night?
Symptom relief Recruiting nowSingle center, prospective, Open label study of sleep, pruritus and circadian function pre/post 12-weeks of dupilumab treatment in children 6-17 years old
Phase: PHASE4 • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New study combines three therapies to help chronic pain patients on opioids
Symptom relief Recruiting nowThis study will sequentially evaluate three novel and scalable interventions for at-risk individuals on long term opioid therapy for chronic pain: (1) low-dose transdermal buprenorphine initiation without a period of opioid withdrawal; (2) a brief Cognitive Behavioral Interventio…
Phase: PHASE1, PHASE2 • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC